Healthcare can be complicated.
Your cardiology news shouldn’t be.
Join thousands of cardiology leaders today.
Cardiology Business April 13, 2026
The Cardiologist Shortage and its Consequences April 13, 2026
We all know there’s a growing cardiologist shortage, but American cardiovascular care might hit its breaking point, with a Medicus Healthcare Solutions analysis now projecting that the […]
Controversies April 9, 2026
Conflict of Interest Allegation Leads to Cardiologist’s Termination April 9, 2026
UPMC’s structural heart president, Hemal Gada, MD, might have been terminated for whistleblowing, according to a federal lawsuit that alleges retaliatory firing following his reports of conflicts […]
Atrial Fibrillation April 6, 2026
CHAMPION-AF: When Noninferiority is Not Enough April 6, 2026
ACC.26 saw an overall drop in research fervor, but one long-awaited study, CHAMPION-AF, spurred a new discussion around the field of left atrial appendage closure and the […]
Cardiology April 2, 2026
The Top Trends of ACC.26 April 2, 2026
Cardiology came back to New Orleans with ACC.26 and amid the magic of “The Big Easy” some more subtle trends emerged, reflecting a maturation of cardiac science […]
More Stories
Cardiology Policy March 30, 2026
A Plan to Tackle CAD Mortality by 2050 March 30, 2026
Coronary artery disease is the leading cause of cardiovascular death throughout the world, and a Lancet commission just released a new statement about what it will take […]
Cardiac Imaging March 26, 2026
What Can Fat Around the Heart Tell Us? March 26, 2026
We all know by now that too much body fat isn’t good for your heart, and new research suggests that the fat directly around your heart could […]
Women's Cardiac Health March 23, 2026
The CV Risks of Premature Menopause March 23, 2026
Keeping a close eye on women’s reproductive health could give insights into their future cardiovascular risk after a new JAMA study found that women who experience premature […]
Population Health March 19, 2026
Ultraprocessed Foods are Bad for Everyone and Worse for Some March 19, 2026
We already know that what you put in your body is directly related to your overall health, including cardiovascular risk, but a new JACC study suggests your […]
Population Health March 16, 2026
Where We’ve Been, and Where We’re Going in CV Health March 16, 2026
JACC released its inaugural Cardiovascular Statistics 2026 report covering a wide spectrum of major CV risk factors and conditions, and despite the medical advancements in the last […]
Cardiac Imaging March 12, 2026
IVI or Angiography for Complex PCI Guidance? March 12, 2026
New follow-up data from the RENOVATE-COMPLEX-PCI trial suggests that intravascular imaging continues to provide better clinical outcomes for patients with complex coronary lesions five years after their […]
Heart Failure March 9, 2026
Barostim Boosts QoL and LVEF, but Mortality Benefit Still Unknown March 9, 2026
Strong results from two separate studies on CVRx’s Barostim baroreflex activation therapy suggest the technology might offer symptomatic relief even though its mortality benefit is still up […]
Cardiology Testing March 5, 2026
What NT-proBNP Can Tell Us About TEER Outcomes March 5, 2026
New research presented at THT 2026 suggests that the NT-proBNP biomarker could give us a glimpse into which patients with severe tricuspid regurgitation (TR) will benefit the […]
Cardiology Testing March 2, 2026
Two Cardiac Troponins Don’t Tell the Same Story March 2, 2026
There might be a bigger difference between the types of cardiac troponin assays, after a recent JACC analysis found that the type of troponin could help us […]
Cardiovascular Disease February 26, 2026
Women’s CVD Will Keep Rising by 2050 February 26, 2026
Imagine an America where two out of three women suffer from cardiovascular disease. What would it look like for your mother, sister, or daughter? The American Heart […]
Surgeries & Interventions February 23, 2026
Market Competition Drives TAVR Overutilization February 23, 2026
Whether or not a patient receives TAVR over SAVR might be more influenced by market forces than clinical evidence, after a recent study found that the more […]
Heart Failure February 19, 2026
Rethinking Hyperkalemia Care in Patients With Heart Failure February 19, 2026
By Ravi Dhingra, MD, MPH, FACC, FAHASponsored By AstraZeneca Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy is a cornerstone of heart failure (HF) management, yet concerns about hyperkalemia (HK) […]
Surgeries & Interventions February 19, 2026
Evolut Low Risk, A Tale of Two Outcomes February 19, 2026
We might need to reconsider the concept of a TAVR-first strategy for low-risk aortic stenosis patients, after extended results from the Evolut Low Risk trial showed that […]
Cardiology Pharmaceuticals February 16, 2026
DAPT Drugs Matter to Diabetics with Multivessel CAD February 16, 2026
The debate over which dual antiplatelet therapy is best for diabetic CAD patients might favor generic prasugrel over ticagrelor (AstraZeneca’s Brilinta), after the TUXEDO-2 trial demonstrated that […]
Artificial Intelligence February 12, 2026
Google’s AMIE Shows Promise for Cardiology Care February 12, 2026
AI scribes and LLMs’ potential impact on cardiology just became a lot clearer after a Stanford RCT published in Nature Medicine demonstrated that Google’s AMIE system helped […]
Cardiology Pharmaceuticals February 9, 2026
Statin Side Effects Might Not be So Bad February 9, 2026
New research in The Lancet suggests that statin underutilization might stem from unfounded safety fears rather than actual risk, after researchers found that 62 out of 66 […]
Cardiology Business February 5, 2026
Medtronic Acquires CathWorks, Expands Cath Lab Presence February 5, 2026
Using AI algorithms to diagnose and assess coronary artery disease for intervention is about to become more mainstream after medtech giant, Medtronic, agreed to exercise its acquisition […]
Cardiology Pharmaceuticals February 2, 2026
CKM’s True Medication Burden February 2, 2026
As cardiology begins to look at the spectrum of cardiovascular-kidney-metabolic disease, new research in JAMA suggests that CKM treatments might face serious adoption challenges due to the […]